The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers

Transfusion

Volumn 51, Issue 9, 2011, Pages 1909-1918

  Ke, Ling ^{a,b,c,d,e,f,g}   He, Miao ^{a,b,c,d,e,f,g}   Li, Changqing ^{a,b,c,d,e,f,g}   Liu, Yu ^{a,b,c,d,e,f,g}   Gao, Lei ^{a,b,c,d,e,f,g}   Yao, Fuzhu ^{a,b,c,d,e,f,g}   Li, Julin ^{a,b,c,d,e,f,g}   Bi, Xinhong ^{a,b,c,d,e,f,g}   Lv, Yunlai ^{a,b,c,d,e,f,g}   Wang, Jingxing ^{a,b,c,d,e,f,g}   Hirsch, Matthew L ^{a,b,c,d,e,f,g}   Li, Wuping ^{a,b,c,d,e,f,g}  

^a INSTITUTE OF BLOOD TRANSFUSION   (China)

^b Yunnan Kunming Blood Center   (China)

^c Guangxi Autonomous Region Blood Center   (China)

^d Urumqi Blood Center of Xinjiang Uygur Autonomous Region   (China)

^e Henan Blood Center   (China)

^f INSTITUTE OF PATHOGEN BIOLOGY   (China)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY; VIRUS DNA;

ADULT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BLOOD VOLUME; CHINA; CHINESE; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMAN; HUMAN PARVOVIRUS B19; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID AMPLIFICATION; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN STRUCTURE; SCREENING; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SEROPREVALENCE; VIRUS ISOLATION; VIRUS LOAD;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BLOOD DONORS; CHINA; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMANS; MALE; PARVOVIRUS B19, HUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 79960370458     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03067.x     Document Type: Article

References (47)

1. Lukashov VV, Goudsmit J,. Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses. J Virol 2001; 75: 2729-40. (Pubitemid 32185036)
2. Heegaard ED, Brown KE,. Human parvovirus B19. Clin Microbiol Rev 2002; 15: 485-505. (Pubitemid 34761354)
3. Servant A, Laperche S, Lallemand F, Marinho V, De Saint Maur G, Meritet JF, Garbarg-Chenon A,. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 2002; 76: 9124-34. (Pubitemid 34919871)
4. Cossart YE, Field AM, Cant B, Widdows D,. Parvovirus-like particles in human sera. Lancet 1975; 1: 72-3.
5. Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B,. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A 2005; 102: 12891-6. (Pubitemid 41279460)
6. Candotti D, Etiz N, Parsyan A, Allain JP,. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol 2004; 78: 12169-78. (Pubitemid 39458736)
7. Norja P, Eis-Hubinger AM, Soderlund-Venermo M, Hedman K, Simmonds P,. Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections. J Virol 2008; 82: 6427-33. (Pubitemid 351875120)
8. Cohen BJ, Buckley MM,. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988; 25: 151-3. (Pubitemid 18061270)
9. Kelly HA, Siebert D, Hammond R, Leydon J, Kiely P, Maskill W,. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect 2000; 124: 449-57. (Pubitemid 30623862)
10. Tsujimura M, Matsushita K, Shiraki H, Sato H, Okochi K, Maeda Y,. Human parvovirus B19 infection in blood donors. Vox Sang 1995; 69: 206-12.
11. Vyse AJ, Andrews NJ, Hesketh LM, Pebody R,. The burden of parvovirus B19 infection in women of childbearing age in England and Wales. Epidemiol Infect 2007; 135: 1354-62. (Pubitemid 351148097)
12. Moudgil A, Shidban H, Nast CC, Bagga A, Aswad S, Graham SL, Mendez R, Jordan SC,. Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin. Transplantation 1997; 64: 1847-50. (Pubitemid 28041728)
13. Fattet S, Cassinotti P, Popovic MB,. Persistent human parvovirus B19 infection in children under maintenance chemotherapy for acute lymphocytic leukemia. J Pediatr Hematol Oncol 2004; 26: 497-503. (Pubitemid 39045466)
14. Blaeser F, Kelly M, Siegrist K, Storch GA, Buller RS, Whitlock J, Truong N, Chatila TA,. Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation. Clin Immunol 2005; 117: 231-7. (Pubitemid 43005209)
15. Cassinotti P, Siegl G,. Quantitative evidence for persistence of human parvovirus B19 DNA in an immunocompetent individual. Eur J Clin Microbiol Infect Dis 2000; 19: 886-7.
16. LaMonte AC, Paul ME, Read JS, Frederick MM, Erdman DD, Han LL, Anderson LJ,. Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study. J Infect Dis 2004; 189: 847-51. (Pubitemid 38328186)
17. Lefrere JJ, Servant-Delmas A, Candotti D, Mariotti M, Thomas I, Brossard Y, Lefrere F, Girot R, Allain JP, Laperche S,. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood 2005; 106: 2890-5. (Pubitemid 41510770)
18. Parsyan A, Candotti D,. Human erythrovirus B19 and blood transfusion-an update. Transfus Med 2007; 17: 263-78. (Pubitemid 47197759)
19. Kleinman SH, Glynn SA, Lee TH, Tobler L, Montalvo L, Todd D, Kiss JE, Shyamala V, Busch MP,. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion 2007; 47: 1756-64. (Pubitemid 47438539)
20. Azzi A, Morfini M, Mannucci PM,. The transfusion-associated transmission of parvovirus B19. Transfus Med Rev 1999; 13: 194-204. (Pubitemid 29323767)
21. Aubin JT, Defer C, Vidaud M, Maniez Montreuil M, Flan B,. Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation. Vox Sang 2000; 78: 7-12. (Pubitemid 30137945)
22. Baylis SA, Shah N, Minor PD,. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma. J Virol Methods 2004; 121: 7-16. (Pubitemid 39180020)
23. Ponnazhagan S, Woody MJ, Wang XS, Zhou SZ, Srivastava A,. Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2. J Virol 1995; 69: 8096-101.
24. Baylis SA, Chudy M, Blumel J, Pisani G, Candotti D, Jose M, Heath AB,. Collaborative study to establish a replacement World Health Organization International Standard for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays. Vox Sang 2010; 98: 441-6.
25. Suzuki M, Yoto Y, Ishikawa A, Tsutsumi H,. Analysis of nucleotide sequences of human parvovirus B19 genome reveals two different modes of evolution, a gradual alteration and a sudden replacement: a retrospective study in Sapporo, Japan, from 1980 to 2008. J Virol 2009; 83: 10975-80.
26. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG,. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25: 4876-82.
27. Tamura K, Dudley J, Nei M, Kumar S,. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24: 1596-9. (Pubitemid 47236692)
28. Shan H, Ren FR, Zhao HY, Zhang YZ, Wen GX, Yao FZ, Gao GJ, Yan LX, Jiang CF, Bai XH, Tiemuer MH, Tu YQ, Zhu FM, Zheng YR, Cui L, Liu CL, Gong XY, Lv QS, Zheng P, Ziermann R, Ness P, Wang JX,. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing. Transfusion 2007; 47: 2011-6. (Pubitemid 47623970)
29. Toan NL, Duechting A, Kremsner PG, Song le H, Ebinger M, Aberle S, Binh VQ, Duy DN, Torresi J, Kandolf R, Bock CT,. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. J Gen Virol 2006; 87: 2941-9. (Pubitemid 44463903)
30. Koppelman MH, Cuypers HT, Emrich T, Zaaijer HL,. Quantitative real-time detection of parvovirus B19 DNA in plasma. Transfusion 2004; 44: 97-103. (Pubitemid 38177143)
31. Aberham C, Pendl C, Gross P, Zerlauth G, Gessner M,. A quantitative, internally controlled real-time PCR assay for the detection of parvovirus B19 DNA. J Virol Methods 2001; 92: 183-91. (Pubitemid 32171986)
32. Nguyen QT, Wong S, Heegaard ED, Brown KE,. Identification and characterization of a second novel human erythrovirus variant, A6. Virology 2002; 301: 374-80. (Pubitemid 35176561)
33. Nguyen QT, Sifer C, Schneider V, Allaume X, Servant A, Bernaudin F, Auguste V, Garbarg-Chenon A,. Novel human erythrovirus associated with transient aplastic anemia. J Clin Microbiol 1999; 37: 2483-7. (Pubitemid 29337266)
34. Hokynar K, Soderlund-Venermo M, Pesonen M, Ranki A, Kiviluoto O, Partio EK, Hedman K,. A new parvovirus genotype persistent in human skin. Virology 2002; 302: 224-8.
35. Heegaard ED, Panum Jensen I, Christensen J,. Novel PCR assay for differential detection and screening of erythrovirus B19 and erythrovirus V9. J Med Virol 2001; 65: 362-7.
36. Jordan J, Tiangco B, Kiss J, Koch W,. Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Vox Sang 1998; 75: 97-102. (Pubitemid 28490878)
37. McOmish F, Yap PL, Jordan A, Hart H, Cohen BJ, Simmonds P,. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol 1993; 31: 323-8. (Pubitemid 23028634)
38. Anderson LJ, Tsou C, Parker RA, Chorba TL, Wulff H, Tattersall P, Mortimer PP,. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol 1986; 24: 522-6. (Pubitemid 16014542)
39. Manaresi E, Gallinella G, Venturoli S, Zerbini M, Musiani M,. Detection of parvovirus B19 IgG: choice of antigens and serological tests. J Clin Virol 2004; 29: 51-3. (Pubitemid 37524087)
40. Zaaijer HL, Koppelman MH, Farrington CP,. Parvovirus B19 viraemia in Dutch blood donors. Epidemiol Infect 2004; 132: 1161-6. (Pubitemid 39642399)
41. Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS,. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989; 84: 1114-23. (Pubitemid 19247580)
42. Manaresi E, Gallinella G, Morselli Labate AM, Zucchelli P, Zaccarelli D, Ambretti S, Delbarba S, Zerbini M, Musiani M,. Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors. Epidemiol Infect 2004; 132: 857-62. (Pubitemid 39307342)
43. Lin KH, You SL, Chen CJ, Wang CF, Yang CS, Yamazaki S,. Seroepidemiology of human parvovirus B19 in Taiwan. J Med Virol 1999; 57: 169-73. (Pubitemid 29022510)
44. Parsyan A, Addo-Yobo E, Owusu-Ofori S, Akpene H, Sarkodie F, Allain JP,. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area. Transfusion 2006; 46: 1593-600. (Pubitemid 44326337)
45. Parsyan A, Kerr S, Owusu-Ofori S, Elliott G, Allain JP,. Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic. J Clin Microbiol 2006; 44: 1367-75.
46. Yamashita K, Matsunaga Y, Taylor-Wiedeman J, Yamazaki S,. A significant age shift of the human parvovirus B19 antibody prevalence among young adults in Japan observed in a decade. Jpn J Med Sci Biol 1992; 45: 49-58.
47. Rohrer C, Gartner B, Sauerbrei A, Bohm S, Hottentrager B, Raab U, Thierfelder W, Wutzler P, Modrow S,. Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect 2008; 136: 1564-75.